Article
The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders.
The Lancet. Neurology - 1 Aug 2018
Carmona Susana, Zahs Kathleen, Wu Elizabeth, Dakin Kelly, Bras Jose, Guerreiro Rita
Abstract excerpt
Alzheimer's disease is a genetically complex disorder; rare variants in the triggering receptor expressed on myeloid cells 2 (TREM2) gene have been shown to as much as triple an individual's risk of developing Alzheimer's disease. TREM2 is a transmembrane receptor expressed in cells of the myeloid lineage, and its association with Alzheimer's disease supports the involvement of immune and inflammatory pathways in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
